Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4734 (MIR4734) is a small, non-coding RNA gene in humans that produces a mature microRNA molecule via a multi-step process. It is first transcribed as a primary transcript (pri-miRNA) and then processed by enzymes Drosha and Dicer to generate the mature miRNA. The mature MIR4734 is incorporated into the RNA-induced silencing complex (RISC), where it specifically regulates gene expression post-transcriptionally by binding to target mRNAs—generally resulting in translational inhibition or mRNA degradation. The gene is annotated as part of the miRNA family and does not have characterized disease associations, therapeutic drugs, or biomarker applications at present. Its function is typical of the microRNA class, which has wide-ranging regulatory impacts throughout cellular biology and is essential for fine-tuning gene expression in multicellular organisms.
MicroRNAs regulate gene expression by binding to complementary sequences on target mRNAs, leading to translational inhibition or mRNA destabilization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4734 (MIR4734).